Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Miguel Izquierdo, MD
Clinical Development Oncology, Novartis, Basel, Switzerland, Switzerland
Poster(s):
(318) Risk of Oligospermia with Tyrosine Kiase Inhibitors: A Disproportionality Analysis from Vigibase and AERS Databases
Saturday, August 27, 2022
8:00 AM – 6:00 PM
CEST
(250) The Risk of Posterior Reversible Encephalopathy Syndrome (PRES) with Tyrosine Kinase Inhibitors: A Disproportionality Analysis from Vigibase and AERS Databases
Saturday, August 27, 2022
8:00 AM – 6:00 PM
CEST
